AstraZeneca

GSK, AZ hit with deep price cuts in China on key drugs
Fierce Pharma
Fri, 05/20/16 - 11:50 am
GSK
AstraZeneca
China
drug pricing
Pascal Soriot's big experiment: reinventing AstraZeneca
Yahoo/Reuters
Wed, 05/18/16 - 11:10 am
Pascal Soriot
AstraZeneca
AstraZeneca Announces Positive Results from Benralizumab Phase III Program in Severe Asthma
Yahoo
Tue, 05/17/16 - 09:51 am
AstraZeneca
asthma
severe asthma
benralizumab
AstraZeneca looks to DNA damage-response drugs for edge in oncology
BioPharma Dive
Tue, 05/17/16 - 09:25 am
AstraZeneca
oncology
ASCO
Lynparza
3 Big Pharma Stocks With Credible Threats to Their Blockbusters
24/7 Wall St
Fri, 05/6/16 - 10:52 am
Pfizer
renal cancer
Sutent
cabozantinib
Exelixis
AstraZeneca
Faslodex
breast cancer
Atossa Genetics
Merck
Zetia
Mylan Labs
Takeda renames antidepressant after name confusion leads to errors
BioPharma Dive
Tue, 05/3/16 - 09:49 pm
Takeda
antidepressants
drug names
Brintellix
AstraZeneca
Brilinta
Medivation: Why a Takeover Just Got a Little Tougher
Barron's
Mon, 05/2/16 - 10:03 pm
Medivation
M&A
Sanofi
Pfizer
AstraZeneca
Crestor tumbles off patent cliff as first generic copy approved in US
BioPharma Dive
Mon, 05/2/16 - 10:09 am
Crestor
patents
patent cliff
generics
AstraZeneca
Watson Pharmaceuticals
Pfizer and AstraZeneca might create some headache for Sanofi in its attempts to buy the biotech company Medivation
Bidness, ETC
Mon, 05/2/16 - 10:03 am
Pfizer
Sanofi
Medivation
AstraZeneca
M&A
AstraZeneca, Pfizer Said Among Firms Weighing Medivation Bid
Bloomberg
Sat, 04/30/16 - 11:45 am
AstraZeneca
Pfizer
Sanofi
Medivation
M&A
AstraZeneca Gains on New Cost-Cutting Plans
Bidness, ETC
Fri, 04/29/16 - 10:57 am
AstraZeneca
earnings
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
BioPharma Dive
Wed, 04/27/16 - 02:11 pm
AstraZeneca
Zurampic
Ironwood Pharmaceuticals
gout
AstraZeneca launches massive drug discovery effort, aims to sequence 2 million genomes
BioPharma Dive
Fri, 04/22/16 - 11:06 am
AstraZeneca
genome sequencing
drug discover
R&D
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
FDA
diabetes
AstraZeneca
Takeda
Nesina
Onglyza
Eli Lilly
JNJ
Trajenta
Jardiance
Invokana
Report: AstraZeneca considering bid for cancer biotech Medivation
BioPharma Dive
Mon, 04/18/16 - 09:44 am
AstraZeneca
Medivation
Sanofi
M&A
Xtandi
Diabetes drugs fuel cancer spread in mouse study
Stat
Wed, 04/13/16 - 10:26 pm
diabetes
cancer
Merck
Januvia
AstraZeneca
Onglyza
Two drug makers complain India is thwarting licenses for selling generics
Stat
Wed, 04/13/16 - 11:46 am
India
Lee Pharma
BDR Pharma
generics
Sprycel
Bristol-Myers Squibb
AstraZeneca
Onglyza
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Medivation
M&A
Amgen
Gilead Sciences
Sanofi
AstraZeneca
3 Nominations for Big Pharma's Riskiest Pipeline -- and Why They Qualify
Motley Fool
Tue, 04/12/16 - 10:37 am
GSK
oncology
Bristol-Myers Squibb
AstraZeneca
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira

Pages